BIOMAT Database Logo BIOMAT Database Logo

Severe aplastic anaemia following leflunomide therapy. 2010

Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077339 Leflunomide An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. Arava,HWA 486,HWA-486,N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide,SU101,HWA486
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D018501 Antirheumatic Agents Drugs that are used to treat RHEUMATOID ARTHRITIS. Anti-Rheumatic Agent,Anti-Rheumatic Drug,Antirheumatic Agent,Antirheumatic Disease-Modifying Second-Line Drug,Antirheumatic Drug,DMARD,Disease-Modifying Antirheumatic Drug,Disease-Modifying Antirheumatic Drugs,Anti-Rheumatic Agents,Anti-Rheumatic Agents, Non-Steroidal,Anti-Rheumatic Drugs,Antirheumatic Disease-Modifying Second-Line Drugs,Antirheumatic Drugs,Antirheumatic Drugs, Disease-Modifying,Disease-Modifying, Antirheumatic Second-Line Drugs,Agent, Anti-Rheumatic,Agent, Antirheumatic,Anti Rheumatic Agent,Anti Rheumatic Agents,Anti Rheumatic Agents, Non Steroidal,Anti Rheumatic Drug,Anti Rheumatic Drugs,Antirheumatic Disease Modifying Second Line Drug,Antirheumatic Disease Modifying Second Line Drugs,Antirheumatic Drug, Disease-Modifying,Antirheumatic Drugs, Disease Modifying,Disease Modifying Antirheumatic Drug,Disease Modifying Antirheumatic Drugs,Disease Modifying, Antirheumatic Second Line Drugs,Drug, Anti-Rheumatic,Drug, Antirheumatic,Drug, Disease-Modifying Antirheumatic,Non-Steroidal Anti-Rheumatic Agents

Related Publications

Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Severe aplastic anaemia following hepatitis A.
January 1986, Acta haematologica,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Aplastic anaemia following sulfonamide therapy.
April 1956, Canadian Medical Association journal,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Severe aplastic anaemia.
April 1985, Archives of disease in childhood,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Pernicious anaemia associated with aplastic anaemia following phenylbutazone therapy.
August 1962, The Medical journal of Australia,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Fatal aplastic anaemia following sulphaphenazole (Orisulf) therapy.
August 1963, Postgraduate medical journal,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Jaundice and aplastic anaemia following chloramphenicol therapy.
October 1957, The New Zealand medical journal,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Aplastic anaemia and agranulocytosis following chlorpromazine therapy.
January 1960, The Medical journal of Australia,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Death from aplastic anaemia following methyl thiouracil therapy.
August 1957, The Medical journal of Australia,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Aplastic anaemia following neoarsphenamine.
June 1949, British medical journal,
Mirjam Wüsthof, and Anna Smirnova, and Ulrike Bacher, and Nicolaus Kröger, and Axel Rolf Zander, and Gunter Schuch, and Carsten Bokemeyer
Aplastic anaemia following penicillamine.
August 1974, Postgraduate medical journal,
Copied contents to your clipboard!